Looks like you can still buy below 0.75 (if you want to...but do you???)

are you still in EDAP???

did you set up this board??

FANTASTIC NEWS OUT TODAY ..PMBS WILL EXPLODE TODAY !!!
http://finance.yahoo.com/news/PuraMed-BioScience-Inc-pz-1282661296.html?x=0&.v=1

PuraMed BioScience, Inc. Announces Completion of Manuscript of Clinical Study of LipiGesic(TM) M and Submission to Top-Ranked Medical Journal




Last chance to buy at 75c before it jumps over 1 US$ ! THIS LOW FLOAT STOCK COULD JUMP TO $6++ WITHIN SECONDS . GOOD LUCK ALL !

http://www.otcmarkets.com/stock/pmbs/quote

MPID Ask Price Size Date/Time

NITE ---0.75------5000 <<
DOMS ---1.40------500 <<
HDSN ---1.50------500
VFIN ---1.70------500

Major BREAKOUT COMING

Take a look at this Ask :

http://www.otcmarkets.com/stock/pmbs/quote

NITE 0.5101 2500 13:10
ETMM 0.60 2500 13:22
DOMS 0.85 2500 11/12
HDSN 1.50 500 10:39
VFIN 1.70 500 11/16

Last chance to load up cheap shares under 1 dollar

THIS IS THE ASK SIDE:

NITE 0.50 5000
AUTO 0.50 5000
HDSN 0.75 2500
DOMS 0.85 2500

GET IN NOW BEFORE ITS TOO LATE .

RALLLYYYYYYYYYYYYYYYYYYYYYYY

PMBS.PK EXPLODING .. THIS IS JUST THE BEGINNING


3 Drugs to enter the market in 1Q 2011 . Market cap of 4 Mil is really a big joke .

ENJOY THE RIDE .

Please click link and look at ASK !!
http://www.otcmarkets.com/stock/pmbs/quote

ASK:

VERT 0.275 5000 << Last shares then jump to 49c
HDSN 0.49 5000 <<


GET IN NOW OR MISS THE BIG OPPORTUNITY !

MAJOR BREAKOUT COMING ANY TIME NOW :::::

http://www.otcmarkets.com/stock/pmbs/quote

THIS IS THE ASK:( COULD EXPLODE TODAY )

NITE 0.34 5000 12/22 <<
DOMS 0.85 2500 11/12 <<
HDSN 1.10 500 12/22
VFIN 1.70 500 11/16



3 Major Drugs to be launched into Market in 1Q11 .Market cap of 5 million$ is a big joke .This undiscovered low float stock will explode like VRML or HGSI .



Puramed (PMBS.PK)

Market Cap: 5 M$
Cash : 5 M$ agreement with Lincoln capital Fund (june 2010)
Price 0,34 $


Shares Out: 14.1 M ...( 9 million shares held by Directors )
Low Float : 5 M



How many products does PuraMed BioScience have in progress?

LipiGesic M for the relief of migraine headaches is the first PuraMed product that will be introduced to the market. Following its entrance into the market, two other products, LipiGesic PM for insomnia and LipiGesic H for tension headaches, will be developed and introduced. There are also product formulations for relief from canker sores, restless-leg syndrome, nighttime-reflux disorders, smoking cessation, and weight loss that will soon follow.

PuraMed was established to capture two unique opportunities. The first is to build a substantial and profitable business, rapidly, beginning with three products developed by its founders: LipiGesic™ M (for acute relief of migraine headaches), LipiGesic™ H(for acute relief of tension headaches) and PuraMed™ PM (for insomnia). Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative health remedy market by introducing a “new kind of product line.” Our product line will consist of ‘alternative’ remedies for common ailments, marketed to the masses. Most consumers want products that are, first of all, effective and safe. By applying hard science to ‘natural’ products, management believes it is possible to build a line wherein each product delivers better performance with fewer side effects than its chemical counterparts. With effective marketing, these products will be embraced by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

PuraMed BioScience, Inc will enter the OTC (Over-The-Counter) medicine marketplace by employing direct to consumer marketing and applying broad retail distribution and effective marketing to several unique products now developed and known to be effective. The company intends to launch its first two retail products within six months and leverage that success to ultimately become a leader in the OTC medicine marketplace.

THE SAME MANAGEMENT WILL BRING THE LIPIGESIC PRODUCTS TO MARKET NEXT Q .DO YOU KNOW WHAT WILL HAPPEN WITH THE SHARE PRICE IF THEY REACH THE SAME NUMBERS WITH LIPIGESIC ??? BOOM TO ORBIT !!

MARKET CAP : $5 MIL


Product development and design packaging of all PuraMed products have been conducted entirely by the Company's two principal officers, Russell Mitchell and James Higgins: Messrs. Mitchell and Higgins have extensive and lengthy experience in new product development and marketing of non-prescription medical products and nutritional supplements and the many varied promotional activities involved in their marketing rollouts. For example, Mitchell Health Technologies served as the master broker for the launch of Quigley Corp's "Cold-Eeze" treatment for common colds, which within 18 months exceeded $70 million in annual wholesale revenues. The Company considers the long and successful professional involvement of its management team in our industry to be a valuable asset to draw upon to achieve the future growth and profitability anticipated by the Company.

http://www.otcmarkets.com/stock/pmbs/quote

Take a look at this ASK .. This stock is ready to take off .

AUTO 0.35 5000
NITE 0.40 5000
HDSN 0.402 5000
DOMS 0.85 2500
VFIN 1.70 500


Get in now before the stock gets discovered

LOAD UP THE TRUCK WITH CHEAP SHARES

MARKET LAUNCH NEWS FOR THEIR MIRGAINE DRUG COMING ANY DAY NOW

Buy 10k shares and this stock will move over 1 dollar . Pmbs is the next VRML .

Look at Ask :

HDSN 0.51 2500 12/21
NITE 0.55 2500 12/21
DOMS 0.85 2500 11/12
VFIN 1.70 500 11/16

3 Big Drugs to be launched on the Market in 1Q11 .Market cap of 7 million$ is a big joke .

Get in now before the stock gets Discovered !!! Easy money at this level .


Puramed (PMBS.PK)

Market Cap: 7,2 M$
Cash : 5 M$ agreement with Lincoln capital Fund (june 2010)
Price 0,51 $


Shares Out: 14.1 M ...( 12 million shares held by insiders )
Low Float : 5 M



How many products does PuraMed BioScience have in progress?

LipiGesic M for the relief of migraine headaches is the first PuraMed product that will be introduced to the market. Following its entrance into the market, two other products, LipiGesic PM for insomnia and LipiGesic H for tension headaches, will be developed and introduced. There are also product formulations for relief from canker sores, restless-leg syndrome, nighttime-reflux disorders, smoking cessation, and weight loss that will soon follow.

PuraMed was established to capture two unique opportunities. The first is to build a substantial and profitable business, rapidly, beginning with three products developed by its founders: LipiGesic™ M (for acute relief of migraine headaches), LipiGesic™ H(for acute relief of tension headaches) and PuraMed™ PM (for insomnia). Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative health remedy market by introducing a “new kind of product line.” Our product line will consist of ‘alternative’ remedies for common ailments, marketed to the masses. Most consumers want products that are, first of all, effective and safe. By applying hard science to ‘natural’ products, management believes it is possible to build a line wherein each product delivers better performance with fewer side effects than its chemical counterparts. With effective marketing, these products will be embraced by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

PuraMed BioScience, Inc will enter the OTC (Over-The-Counter) medicine marketplace by employing direct to consumer marketing and applying broad retail distribution and effective marketing to several unique products now developed and known to be effective. The company intends to launch its first two retail products within six months and leverage that success to ultimately become a leader in the OTC medicine marketplace.

wow, it doesnt get much thinner than that doesnt it?

RALLLYYYYYYYYYYYYYYYYYYYYYYYYYY

PMBS.PK is flying away woohooo

Up she goes baby

http://ih.advfn.com/p.php?pid=webchart&symbol=PMBS&period=0&size=19&volume=1


looak at ask LOL this stock will explode with a few buyers .

MPID Ask Price Size Date/Time

AUTO 0.23 5000 14:31
HDSN 0.35 5000 12:11
NITE 0.42 5000 11:50
DOMS 0.85 2500 11/12
VFIN 1.70 500 11/16

Puramed will launch 3 big drugs in 1Q 2011.
If you like EDAP you will like PMBS too .Market cap of 2,8 million$ is massive undervalued . This stock is under Radar .

Get in now before the stock gets Discovered !!! Easy money at this level .


Puramed (PMBS.PK)

Market Cap: 2,8 M$
Cash : 5 M$ agreement http://puramedbioscience.com/PR/2010_PuraMed_PR-Jun%201%202010.pdf

Price 0,19 $


Shares Out: 14.1 M ...( 9 million shares held by insiders )
Low Float : 5 M


A MUST READ ......
http://www.puramedbioscience.com/PuraMed%20Corp%20Profile-4.2010.pdf


Only a few shares available below 1 Dollar
http://www.otcmarkets.com/stock/pmbs/quote




Why Puramed Bioscience Inc. (PMBS.OB) Should Be On Your Radar

PuraMed Bioscience, Inc. is a pharmaceutical company focused on developing and marketing a line of new, non-prescription medicines. These products target major consumer health needs, including the treatment of headaches, insomnia, and general pain. The company aims launch its first retail products within six months, and then leverage that success to become a leader in the Over-the-Counter (OTC) medicine marketplace.

Although PuraMed Bioscience is entering into a competitive market, the company’s products promise to bring innovation to the industry, allowing for faster absorption into the blood stream, greater effectiveness, fewer side effects, and lower dosage requirements. The first three products the company plans to introduce include: LipiGesic M™ (for acute relief of migraine headaches), LipiGesic H™ (for acute relief of tension headaches) and LipiGesic PM™ (for insomnia).

PuraMed is already sufficiently funded via private funding and ready to move forward with the execution of its comprehensive business plan. Recently BrokerBank analyst Philip Wright, CFA initiated investment coverage of the company and has rated the company as a “speculative buy”. Wright praised the company for running on a lean basis by keeping salaries reasonable and office overhead costs extremely low.

The share structure of the stock is also attractive with only 14,129,246 shares of common stock outstanding as of last month. PuraMed is also a fully reporting company, meaning the company must be audited by a PCAOB registered public accounting firm and must comply with the requirements of Sarbanes-Oxley. These requirements allow for greater transparency and the ability to attract a larger investor audience, subsequently enhancing shareholder value and providing greater access to capital for further growth.

With a management team bringing more than 80 years of combined industry experience, a product line addressing major healthcare needs with many competitive advantages, and a well thought-out business plan, this company is well on its way to success in the multi-billion dollar OTC medicine market. Continue to watch this company as it strives to dramatically improve the quality of life for millions of Americans.